Veracyte VCYT Business Segments — G&A

Similar metrics at other companies

WAYReportable Segment — G&A

$30.72M+31.9%

PCVXReportable Segment — G&A

$33.07M+1.3%

YETIReportable Segment — G&A

$42.29M+15.8%

HNGEReportable Segment — G&A

$19.31M+15.6%

GBTGReportable Segment — G&A

$71M+57.8%

DLBReportable Segment — G&A

$64.14M+10.6%

Questions, answered.

What is Veracyte's business segments — G&A?

Veracyte (VCYT) reported business segments — G&A of $23.68M in Q1 2026.

How has Veracyte's business segments — G&A changed year-over-year?

Veracyte's business segments — G&A decreased by 30.0% year-over-year, from $33.81M to $23.68M.

What is the long-term trend for Veracyte's business segments — G&A?

Over 3 years (2022 to 2025), Veracyte's business segments — G&A has grown at a 14.8% compound annual growth rate (CAGR), from $73.2M to $110.78M.

What does business segments — G&A mean?

This metric aggregates the total costs associated with the administrative, executive, and support functions of the reportable segment. It reflects the overhead required to manage the segment's day-to-day operations, including personnel, facilities, and corporate governance. Tracking this figure is essential for evaluating the segment's operational leverage and cost structure.